The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Granules recalls 33,000+ bottles of Metoprolol Succinate due to failed dissolution specifications, per FDA enforcement report ...

In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...

Lower-income countries, including South Africa, gain unprecedented access to lenacapavir, a revolutionary HIV prevention drug ...

South Carolina cooks may want to be extra cautious when cooking meat after considering a new report that showed more than a ...

Shanghai Zhimeng Biopharma, Inc. ('Zhimeng Biopharma'), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and central nervous system (CNS) diseases, today ...

India and Brazil signed six agreements, including on the exchange of information in the security domain, agricultural ...

Molecules that build coenzyme Q10, vital for mitochondrial function, healed mice and a patient with an ultra-rare and lethal ...

The American Principles Project (APP) is calling on the Trump administration to take additional steps to protect children ...

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...

Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

Inovio Pharmaceuticals (NASDAQ:INO) stock rises as Piper Sandler issues new Overweight rating, citing FDA approval for its lead drug INO-3107 next year. Read more here.